No evidence for taxane/platinum pharmacogenetic markers: just lack of power?
Vach
Werner
W
Bergmann
Troels K
TK
Brøsen
Kim
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000008:administration & dosage; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D005260:Female; D005819:Genetic Markers; D005838:Genotype; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D011110:Polymorphism, Genetic; D012107:Research Design; D043823:Taxoids / Q000008:administration & dosage; D016896:Treatment Outcome
D001952:Bridged-Ring Compounds; D005819:Genetic Markers; D043823:Taxoids; C080625:taxane; D016190:Carboplatin; D002945:Cisplatin